Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage
NCT: NCT07246473 · RECRUITING
Brief Summary
Intracerebral hemorrhage (ICH) is one of the stroke subtypes with the highest global rates of disability and mortality, accounting for 15%-20% of all strokes. Currently, there is a lack of evidence-based interventions for ICH, with treatment primarily relying on supportive care. There is an urgent clinical need to explore new strategies and technologies. The investigators hypothesize that for ICH patients, best medical treatment combined with a non-invasive ultrasonic scalpel (ultrasound Doppler flow analyzer) may be superior to best medical treatment alone. The primary objective of this study is to determine the safety and efficacy of the non-invasive ultrasonic scalpel in promoting hematoma clearance in ICH patients.
Frequently Asked Questions
What is Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage?
Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage is a clinical trial registered under NCT07246473. Current status: RECRUITING.
What is the status of NCT07246473?
The current status of NCT07246473 (Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage) is: RECRUITING.
When did Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage start?
Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage started on 2025-12-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.